MONTGOMERY, Texas--(BUSINESS WIRE)--Endovasc, Inc - (OTCBB:EVSC) a Business Development Company focused on acquiring and investing in companies engaged in the development of innovative cardiovascular and metabolic drugs as well as nutraceutical supplements, is pleased to announce the appointment of Mr. Sam Lindsey as the Company’s new Chief Financial Officer and Chief Compliance Officer. The appointment was effective January 5, 2007.